The Centers for Disease Control and Prevention recommends PrEP as a key HIV prevention measure. Community pharmacists are well positioned to help combat HIV—including its stigma and associated barriers to clinical engagement. This session will focus on key components of providing PrEP, including several jurisdiction-specific challenges, infrastructure, and the training necessary to help expand practice. Speakers will explore two models, in Washington and California, in which patients access PrEP care at the pharmacy counter and will share their successes and challenges.
This activity is supported by an independent educational grant from Gilead Sciences.
At the completion of this application-based activity, participants will be able to
- Summarize data supporting PREP efficacy, adherence, and safety.
- Apply the appropriate guideline-based laboratory testing and monitoring parameters for patients on PrEP.
- Identify culturally competent communication skills necessary for an open patient–pharmacist dialogue when screening and counseling patients for PrEP.
- Identify common challenges for pharmacists establishing a PrEP programs.
Activity type: Application-based
Target Audience: Pharmacists and Pharmacy Technicians
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 2.0 contact hours of CPE credit (0.2 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-028-H02-P/T.
To obtain credit for completing Expanding Your Scope to Fight HIV: Implementing PrEP in Your Pharmacy, participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education assessment. Please note that you will not be permitted to submit the assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.Initial release date: March 23, 2020
Expiration date: March 22, 2023 - No credit granted after this date
Development and Support
Expanding Your Scope to Fight HIV: Implementing PrEP in Your Pharmacy is an activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association. This activity is supported by an independent educational grant from Gilead Sciences. © 2020 American Pharmacists Association
Maria Lopez, PharmD, AAHIVP received funding from the San Francisco Department of Public Health and the Centers for Disease Control and Prevention; Elyse Tung, PharmD, BCACP received honoraria for advisory boards and speaker’s bureau participation from Gilead Sciences, Inc.
APhA’s editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA2020 Virtual Education package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-20-028-H02-P||0.2 CEUs||March 20, 2020 - March 20, 2023|
|ACPE# 0202-0000-20-028-H02-T||0.2 CEUs||March 20, 2020 - March 20, 2023|